SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-20-003750
Filing Date
2020-05-15
Accepted
2020-05-15 06:13:35
Documents
48
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_051520p.htm 10-Q 635179
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8509
3 EXHIBIT 31.2 exh_312.htm EX-31.2 8332
4 EXHIBIT 32.1 exh_321.htm EX-32.1 5586
5 EXHIBIT 32.2 exh_322.htm EX-32.2 5770
12 GRAPHIC development.jpg GRAPHIC 36730
  Complete submission text file 0001171843-20-003750.txt   3053482

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE snca-20200331.xml EX-101.INS 417205
7 XBRL SCHEMA FILE snca-20200331.xsd EX-101.SCH 36550
8 XBRL CALCULATION FILE snca-20200331_cal.xml EX-101.CAL 30042
9 XBRL DEFINITION FILE snca-20200331_def.xml EX-101.DEF 246913
10 XBRL LABEL FILE snca-20200331_lab.xml EX-101.LAB 259696
11 XBRL PRESENTATION FILE snca-20200331_pre.xml EX-101.PRE 266179
Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33672 | Film No.: 20880468
SIC: 2836 Biological Products, (No Diagnostic Substances)